NutraBlast Boric Life
Natural health product licensed in Canada
- Licence holder
- Cyber Group USA LLC
- NPN or DIN-HM
- 80088602
- Status
- Active licence
- Licence date
- 5 October 2018
- Revision date
- Not provided
- Form
- Suppositoire
- Route of administration
- Vaginale
- Application type
- Non traditionnelle
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| Acide borique Source : Acide borique | 600 mg |
Non-medicinal ingredients
Dioxyde de titane, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 suppositoire | 1 day |
Uses authorised in Canada
May help to reduce the incidence of recurrent Vulvovaginal Candidiasis. Helps reduce the overgrowth of recurrent or resistant vaginal yeast. Traditionally used in herbal medicine for secretions associated with vaginitis. Helps to treat symptoms of recurrent Yeast Vaginitis and Vulvovaginal Candidiasis.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Not for oral use. Keep away from children. Consult a healthcare practitioner if symptoms persist or worsen. If you have been diagnosed with estrogen-dependant cancer, consult a health care practitioner prior to use. If you have a kidney disorder, consult a health care practitioner prior to use.
- Contre-indications
Do not use if you are pregnant or breastfeeding.
- Effets indésirables connus
Discontinue use and consult a healthcare practitioner if you experience vaginal pain, irritation or burning.
Source
Official Health Canada record, licence 80088602
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.